Immunotherapeutic aryl amides
US5736570A · kind A · utility
55Cited by
1References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 15, 1996 |
| Grant date | Apr 7, 1998 |
| Priority date | — |
| Expiry date | Oct 15, 2016 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel aryl amides are inhibitors of tumor necrosis factor .alpha. and can be used to combat cachexia, endotoxic shock, and retrovirus replication. A typical embodiment is N-benzoyl-3-amino-3-(3',4'-dimethoxyphenyl)propanamide.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.